表纸SALE
市场调查报告书
商品编码
1025678

精神药物市场预测、竞争趋势、增长机会(~ 2026 年):类型、精神药物类型、形式、分销渠道、使用、区域

Global Psychobiotics Market, By Type, By Psychotropic Agent, By Form, By Distribution Channel, By Application, By Region, Competition Forecast & Opportunities, 2026

出版日期: | 出版商: TechSci Research | 英文 112 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

  • 全貌
  • 简介
  • 目录
简介

由于抑鬱症和焦虑症等心理障碍对益生菌的需求不断增长,预计全球精神益生菌市场将会增长。

抑鬱症和焦虑症患者人数的增加预计也将推动未来五年的市场增长。不仅对身体健康而且对心理健康感兴趣的消费者数量正在迅速增加。注重健康的消费者正在积极使用心理生物并将其纳入日常饮食中,预计这将支持未来五年的增长。

本报告探索全球精神生物市场,定义和概述市场,分析新型冠状病毒感染(COVID-19)和其他市场影响因素,分析客户反馈,以及专利趋势、临床试验趋势、市场规模趋势/预测,按类型/精神药物类型/形式/分销渠道/用途细分,按地区/主要国家,竞争环境,市场份额,主要公司简介等进行详细分析。

目录

第 1 章产品概述

第二章调查方法

第 3 章执行摘要

第 4 章 COVID-19 的影响

第五章客户反馈

第 6 章世界市场展望

  • 市场规模/预测
  • 市场份额/预测
    • 按类型
      • 食品补充剂
      • 膳食补充剂
      • 特殊营养素
      • 婴幼儿奶粉
    • 按精神药物类型
      • 链球菌
      • 双歧杆菌
      • 乳酸菌
      • 梭菌
      • 其他
    • 按表格
      • 液体/流体
      • 平板电脑
    • 按分销渠道
      • 零售店
      • 大卖场/超市
      • 药店/药房
      • 在线
    • 按应用
      • 胃肠功能
      • 抗抑鬱药
      • 抗焦虑药
      • 自闭症谱系障碍
      • 注意力缺陷多动障碍
      • 精神分裂症
      • 其他
    • 按公司
    • 按地区
  • 产品市场地图

第七章北美市场分析与预测

  • 市场规模/预测
  • 市场份额/预测
    • 按类型
    • 按精神药物类型
    • 按表格
    • 按分销渠道
    • 按应用程序
    • 按国家/地区

第八章欧洲市场分析与预测

  • 市场规模/预测
  • 市场份额/预测
    • 按类型
    • 按精神药物类型
    • 按表格
    • 按分销渠道
    • 按应用
    • 按国家/地区

第九章亚太市场分析/预测

  • 市场规模/预测
  • 市场份额/预测
    • 按类型
    • 按精神药物类型
    • 按表格
    • 按分销渠道
    • 按应用
    • 按国家/地区

第10章南美市场分析/预测

  • 市场规模/预测
  • 市场份额/预测
    • 按类型
    • 按精神药物类型
    • 按表格
    • 按分销渠道
    • 按应用程序
    • 按国家/地区

第11章中东和非洲市场分析与预测

  • 市场规模/预测
  • 市场份额/预测
    • 按类型
    • 按精神药物类型
    • 按表格
    • 按分销渠道
    • 按应用程序
    • 按国家/地区

第 12 章市场动态

  • 促进因素
  • 挑战

第 13 章市场趋势

第14章临床试验

第十五章专利分析

第16章竞争形势

  • 竞争前景
  • 公司简介
    • InnovixLabs
    • Bened Biomedical Co., Ltd
    • Nutrimmun GmbH
    • Kerry Group Plc.
    • Sabinsa Corporation
    • Lallemand Health Solutions Inc.
    • DuPont de Nemours, Inc.
    • Uplift Food Pty Ltd.
    • Nature's Bounty Co. Ltd.
    • BioGaia Group
    • The Life Extension Foundation
    • Lifted Naturals

第 17 章战略建议

第 16 章关于我们和免责声明

目录
Product Code: 7678

The growth of Global psychobiotics market in the forecast period, 2022-2026 can be attributed to the rising demand of the probiotics for the psychological ailments like depression and anxiety. Additionally, rising instances of depression and anxiety among the population at large is driving the growth of the global psychobiotics market in the next five years. Moreover, the number of consumers concerned about mental health as well as physical health is rapidly increasing. The consumers are concerned about the over the counter available psychobiotics drugs that may or may not cause adverse effects on the consumers' physical health. Mental illness is also rapidly affecting the population, especially the young population. Health conscious and woke population is actively utilizing the availability of these psychobiotics and incorporating them in their daily food routines, thereby supporting the growth of the global psychobiotics market in the upcoming five years.

The global psychobiotics market is segmented by type, psychotropic agent, form, distribution channel, application, competitional landscape, and regional distribution. Based on type, the market is further segmented into food supplements, nutritional supplements, specialty nutrients, and infant formula. Nutritional supplements are anticipated to hold the largest revenue shares of the market and assert its dominance over the market on the account of rapidly growing number of consumers inclined toward self-medication. The consumers are eagerly adapting the psychobiotics as a nutritional supplement for healthy brain. Large population is suffering from depression, stress and anxiety. The tendency of self-diagnosing and self-medication is very active among the young population and thus they are aiding to the growth of the global psychobiotics market in the upcoming five years forecast, until 2026.

Holding the major shares of the global psychobiotics market are Innovix Labs, Bened Biomedical Co., Ltd, Nutrimmun GmbH, Kerry Group Plc., Sabinsa Corporation, Lallemand Health Solutions Inc., DuPont de Nemours, Inc., Uplift Food Pty Ltd., Nature's Bounty Co. Ltd., BioGaia Group, The Life Extension Foundation, Lifted Naturals, among others. Market players are actively involved in the research and technological development in the medical device and testing kit developments. The advanced technology has made it possible for the healthcare industry to provide excellent healthcare services through psychobiotics. Further advancement would aid the market value and brand establishment in the future five years. New market players may focus on the research and development to provide options that satisfies the consumer demand as well as benefits the market players in building their brand value. Other competitive strategies include mergers & acquisitions and new product developments.

Years considered for this report:

Historical Years: 2016 - 2019

Base Year: 2020

Estimated Year: 2021

Forecast Period: 2022 - 2026

Objective of the Study:

  • To analyze the historical growth of the market size of global psychobiotics market from 2016 to 2019.
  • To estimate and forecast the market size of global psychobiotics market from 2020 to 2026 and growth rate until 2026.
  • To classify and forecast global psychobiotics market based on type, psychotropic agent, form, distribution channel, application, competitional landscape, and regional distribution.
  • To identify dominant region or segment in the global psychobiotics market.
  • To identify drivers and challenges for global psychobiotics market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global psychobiotics market.
  • To identify and analyze the profile of leading players operating in global psychobiotics market.
  • To identify key sustainable strategies adopted by market players in global psychobiotics market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers, suppliers, and distributors across the country. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufactures which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufactures, distribution channels and presence of all major players across the country.

TechSci Research calculated the market size of global psychobiotics market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Manufacturers, end users, and other stakeholders
  • Distributors and suppliers of products and other stakeholders
  • Organizations, forums, and alliances related to psychobiotics
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global psychobiotics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Global Psychobiotics Market, By Type:

Food Supplements

Nutritional Supplements

Specialty Nutrients

Infant Formula

  • Global Psychobiotics Market, By Psychotropic Agents:

Streptococcus

Bifidobacterium

Lactobacillus

Clostridium

Others

  • Global Psychobiotics Market, By Form:

Powder

Liquid/ Fluid

Tablets

  • Global Psychobiotics Market, By Distribution Channel:

Retail Shops

Hypermarkets/ Supermarkets

Drug Store/ Pharmacy

Online

  • Global Psychobiotics Market, By Application:

Gastrointestinal Function

Antidepressant

Anxiolytic

Autism Spectrum Disorder

Attention Deficit Hyperactivity Disorder

Schizophrenia

Others

  • Global Psychobiotics Market, By Region:

North America

  • United States
  • Canada
  • Mexico

Europe

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Slovakia
  • Poland
  • Sweden

Asia-Pacific

  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Singapore
  • Malaysia
  • Taiwan

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE

South America

  • Brazil
  • Argentina
  • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global psychobiotics market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Psychobiotics Market

4. Executive Summary

5. Voice of Customer

  • 5.1. Brand Awareness
  • 5.2. Preferred Mode of Purchase
  • 5.3. Major Factors Contributing to Mental Illness
  • 5.4. Willingness towards Psychobiotics Consumption
  • 5.5. Commonly Observed Psychological Effect Post Consumption

6. Global Psychobiotics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value & Volume
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type (Food Supplements, Nutritional Supplements, Specialty Nutrients, Infant Formula)
    • 6.2.2. By Psychotropic Agent (Streptococcus, Bifidobacterium, Lactobacillus, Clostridium, Others)
    • 6.2.3. By Form (Powder, Liquid/Fluid, Tablets)
    • 6.2.4. By Distribution Channel (Retail Shops, Hypermarkets/Supermarkets, Drug Store/Pharmacy, Online)
    • 6.2.5. By Application (Gastrointestinal Function, Antidepressant, Anxiolytic, Autism Spectrum Disorder, Attention Deficit Hyperactivity Disorder, Schizophrenia, Others)
    • 6.2.6. By Company (2020)
    • 6.2.7. By Region
  • 6.3. Product Market Map

7. North America Psychobiotics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value & Volume
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Psychotropic Agent
    • 7.2.3. By Form
    • 7.2.4. By Distribution Channel
    • 7.2.5. By Application
    • 7.2.6. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Psychobiotics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Psychotropic Agent
        • 7.3.1.2.3. By Form
        • 7.3.1.2.4. By Distribution Channel
        • 7.3.1.2.5. By Application
    • 7.3.2. Mexico Psychobiotics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Psychotropic Agent
        • 7.3.2.2.3. By Form
        • 7.3.2.2.4. By Distribution Channel
        • 7.3.2.2.5. By Application
    • 7.3.3. Canada Psychobiotics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Psychotropic Agent
        • 7.3.3.2.3. By Form
        • 7.3.3.2.4. By Distribution Channel
        • 7.3.3.2.5. By Application

8. Europe Psychobiotics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value & Volume
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Psychotropic Agent
    • 8.2.3. By Form
    • 8.2.4. By Distribution Channel
    • 8.2.5. By Application
    • 8.2.6. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Psychobiotics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Psychotropic Agent
        • 8.3.1.2.3. By Form
        • 8.3.1.2.4. By Distribution Channel
        • 8.3.1.2.5. By Application
    • 8.3.2. Germany Psychobiotics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Psychotropic Agent
        • 8.3.2.2.3. By Form
        • 8.3.2.2.4. By Distribution Channel
        • 8.3.2.2.5. By Application
    • 8.3.3. United Kingdom Psychobiotics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Psychotropic Agent
        • 8.3.3.2.3. By Form
        • 8.3.3.2.4. By Distribution Channel
        • 8.3.3.2.5. By Application
    • 8.3.4. Italy Psychobiotics Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Psychotropic Agent
        • 8.3.4.2.3. By Form
        • 8.3.4.2.4. By Distribution Channel
        • 8.3.4.2.5. By Application
    • 8.3.5. Spain Psychobiotics Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Psychotropic Agent
        • 8.3.5.2.3. By Form
        • 8.3.5.2.4. By Distribution Channel
        • 8.3.5.2.5. By Application
    • 8.3.6. Sweden Psychobiotics Market Outlook
      • 8.3.6.1. Market Size & Forecast
        • 8.3.6.1.1. By Value
      • 8.3.6.2. Market Share & Forecast
        • 8.3.6.2.1. By Type
        • 8.3.6.2.2. By Psychotropic Agent
        • 8.3.6.2.3. By Form
        • 8.3.6.2.4. By Distribution Channel
        • 8.3.6.2.5. By Application
    • 8.3.7. Poland Psychobiotics Market Outlook
      • 8.3.7.1. Market Size & Forecast
        • 8.3.7.1.1. By Value
      • 8.3.7.2. Market Share & Forecast
        • 8.3.7.2.1. By Type
        • 8.3.7.2.2. By Psychotropic Agent
        • 8.3.7.2.3. By Form
        • 8.3.7.2.4. By Distribution Channel
        • 8.3.7.2.5. By Application
    • 8.3.8. Slovakia Psychobiotics Market Outlook
      • 8.3.8.1. Market Size & Forecast
        • 8.3.8.1.1. By Value
      • 8.3.8.2. Market Share & Forecast
        • 8.3.8.2.1. By Type
        • 8.3.8.2.2. By Psychotropic Agent
        • 8.3.8.2.3. By Form
        • 8.3.8.2.4. By Distribution Channel
        • 8.3.8.2.5. By Application

9. Asia-Pacific Psychobiotics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value & Volume
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Psychotropic Agent
    • 9.2.3. By Form
    • 9.2.4. By Distribution Channel
    • 9.2.5. By Application
    • 9.2.6. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Psychobiotics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Psychotropic Agent
        • 9.3.1.2.3. By Form
        • 9.3.1.2.4. By Distribution Channel
        • 9.3.1.2.5. By Application
    • 9.3.2. India Psychobiotics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Psychotropic Agent
        • 9.3.2.2.3. By Form
        • 9.3.2.2.4. By Distribution Channel
        • 9.3.2.2.5. By Application
    • 9.3.3. South Korea Psychobiotics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Psychotropic Agent
        • 9.3.3.2.3. By Form
        • 9.3.3.2.4. By Distribution Channel
        • 9.3.3.2.5. By Application
    • 9.3.4. Japan Psychobiotics Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Type
        • 9.3.4.2.2. By Psychotropic Agent
        • 9.3.4.2.3. By Form
        • 9.3.4.2.4. By Distribution Channel
        • 9.3.4.2.5. By Application
    • 9.3.5. Australia Psychobiotics Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Type
        • 9.3.5.2.2. By Psychotropic Agent
        • 9.3.5.2.3. By Form
        • 9.3.5.2.4. By Distribution Channel
        • 9.3.5.2.5. By Application
    • 9.3.6. Taiwan Psychobiotics Market Outlook
      • 9.3.6.1. Market Size & Forecast
        • 9.3.6.1.1. By Value
      • 9.3.6.2. Market Share & Forecast
        • 9.3.6.2.1. By Type
        • 9.3.6.2.2. By Psychotropic Agent
        • 9.3.6.2.3. By Form
        • 9.3.6.2.4. By Distribution Channel
        • 9.3.6.2.5. By Application
    • 9.3.7. Malaysia Psychobiotics Market Outlook
      • 9.3.7.1. Market Size & Forecast
        • 9.3.7.1.1. By Value
      • 9.3.7.2. Market Share & Forecast
        • 9.3.7.2.1. By Type
        • 9.3.7.2.2. By Psychotropic Agent
        • 9.3.7.2.3. By Form
        • 9.3.7.2.4. By Distribution Channel
        • 9.3.7.2.5. By Application
    • 9.3.8. Singapore Psychobiotics Market Outlook
      • 9.3.8.1. Market Size & Forecast
        • 9.3.8.1.1. By Value
      • 9.3.8.2. Market Share & Forecast
        • 9.3.8.2.1. By Type
        • 9.3.8.2.2. By Psychotropic Agent
        • 9.3.8.2.3. By Form
        • 9.3.8.2.4. By Distribution Channel
        • 9.3.8.2.5. By Application

10. South America Psychobiotics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value & Volume
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Psychotropic Agent
    • 10.2.3. By Form
    • 10.2.4. By Distribution Channel
    • 10.2.5. By Application
    • 10.2.6. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Psychobiotics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Psychotropic Agent
        • 10.3.1.2.3. By Form
        • 10.3.1.2.4. By Distribution Channel
        • 10.3.1.2.5. By Application
    • 10.3.2. Argentina Psychobiotics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Psychotropic Agent
        • 10.3.2.2.3. By Form
        • 10.3.2.2.4. By Distribution Channel
        • 10.3.2.2.5. By Application
    • 10.3.3. Colombia Psychobiotics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Psychotropic Agent
        • 10.3.3.2.3. By Form
        • 10.3.3.2.4. By Distribution Channel
        • 10.3.3.2.5. By Application

11. Middle East and Africa Psychobiotics Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value & Volume
  • 11.2. Market Share & Forecast
    • 11.2.1. By Type
    • 11.2.2. By Psychotropic Agent
    • 11.2.3. By Form
    • 11.2.4. By Distribution Channel
    • 11.2.5. By Application
    • 11.2.6. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Psychobiotics Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Type
        • 11.3.1.2.2. By Psychotropic Agent
        • 11.3.1.2.3. By Form
        • 11.3.1.2.4. By Distribution Channel
        • 11.3.1.2.5. By Application
    • 11.3.2. Saudi Arabia Psychobiotics Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Type
        • 11.3.2.2.2. By Psychotropic Agent
        • 11.3.2.2.3. By Form
        • 11.3.2.2.4. By Distribution Channel
        • 11.3.2.2.5. By Application
    • 11.3.3. UAE Psychobiotics Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Type
        • 11.3.3.2.2. By Psychotropic Agent
        • 11.3.3.2.3. By Form
        • 11.3.3.2.4. By Distribution Channel
        • 11.3.3.2.5. By Application

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Clinical Trials

15. Patent Analysis

16. Competitive Landscape

  • 16.1. Competition Outlook
  • 16.2. Company Profiles (SWOT Analysis of Top 5 Players Profiled)
    • 16.2.1. InnovixLabs
    • 16.2.2. Bened Biomedical Co., Ltd
    • 16.2.3. Nutrimmun GmbH
    • 16.2.4. Kerry Group Plc.
    • 16.2.5. Sabinsa Corporation
    • 16.2.6. Lallemand Health Solutions Inc.
    • 16.2.7. DuPont de Nemours, Inc.
    • 16.2.8. Uplift Food Pty Ltd.
    • 16.2.9. Nature's Bounty Co. Ltd.
    • 16.2.10. BioGaia Group
    • 16.2.11. The Life Extension Foundation
    • 16.2.12. Lifted Naturals

17. Strategic Recommendations

18. About Us & Disclaimer